LightPath Technologies, Inc. — FY2016 Form 10-K
Reporting period: Fiscal year ended June 30, 2016; comparative period is FY2015. The request metadata refers to 2015 Q4, but this filing reports FY2016. The filing was signed September 15, 2016.
Business context
LightPath designs and manufactures precision molded glass optics, infrared lenses, GRADIUM lenses, and optical assemblies for defense, medical, industrial, laser, telecommunications, and other markets. Manufacturing is based in Orlando, Florida, and Zhenjiang, China. The company reports one operating segment.
Financial results and liquidity
| Metric | FY2016 | FY2015 |
|---|---|---|
| Net revenue | $17.27 million | $13.66 million |
| Gross profit / margin | $9.30 million / 53.9% | $5.98 million / 43.8% |
| Operating income (loss) | $2.01 million | ($259,000) |
| Net income (loss) | $1.41 million | ($715,000) |
| Diluted EPS | $0.08 | ($0.05) |
| Operating cash flow | $1.53 million | $82,000 |
| Capital expenditures | $1.13 million | $689,000 |
- At June 30, 2016, cash and cash equivalents were $2.91 million, working capital was approximately $7.94 million, total assets were $15.59 million, and stockholders’ equity was $10.93 million.
- Cash increased from $1.64 million a year earlier. About $1.45 million was held by Chinese subsidiaries; repatriation is restricted until Chinese retained earnings reach a specified threshold. The filing gives differing retained-earnings figures in separate sections, so the precise amount should be verified.
- There was no borrowing outstanding on the AvidBank receivables line at year-end; its maximum availability was the lesser of $1 million or 80% of eligible receivables. Capital lease obligations totaled $345,000, including $166,000 current. The company also disclosed $2.16 million of future operating lease minimum payments.
- Non-GAAP adjusted EBITDA was $2.55 million, versus $320,000 in FY2015; adjusted net income was $1.47 million, versus an adjusted net loss of $251,000. These measures exclude noncash warrant fair-value changes and should be considered alongside GAAP results.
Material changes versus FY2015
- Revenue rose 26%, led by HVPMO sales (+58%), infrared products (+47%), specialty products (+36%), and NRE (+109%); LVPMO revenue increased 4%. Precision molded optics unit shipments rose 17%, with average selling price up 2%.
- Gross margin improved to 53.9% from 43.8%, attributed to higher volume, favorable product mix, fixed-cost leverage, and improved infrared yields and in-house coating.
- SG&A rose $1.45 million to $6.58 million, including higher incentive compensation, technical-sales/new-product-development staffing costs, legal fees associated partly with the proposed ISP acquisition, and other items. New product development expense declined to $669,000 from $1.11 million.
- Operating cash flow improved, but inventory increased to $3.84 million from $3.18 million and receivables increased to $3.55 million from $3.05 million. Year-end 12-month backlog was $6.60 million, up 2% year over year.
Outlook, risks, and unusual items
- Management expected FY2017 sales growth primarily from precision molded optics, particularly HVPMOs, specialty products, and infrared products. It cited quote activity and market trends, but did not provide a specific revenue or earnings forecast. Planned FY2017 product-development spending was approximately $847,000; capital expenditures were expected to increase, with the amount dependent on circumstances.
- On August 3, 2016, LightPath agreed to acquire ISP Optics for $18 million, payable through cash of at least $12 million and a seller note of at least $3 million, subject to adjustments. The note carries 10% interest under the specified terms and matures in five years. Closing remained conditional on financing, shareholder approvals, and other conditions; management anticipated closing in calendar Q4 2016, with no assurance it would close.
- Management said current resources were adequate for the coming year, but warned that weaker sales, higher material or labor costs, unrealized production efficiencies, or increased spending could require additional capital. Failure to obtain capital on reasonable terms could prompt consideration of strategic alternatives, including asset or company sale, joint ventures, or licensing.
- Three customers represented approximately 25% of FY2016 revenue (10%, 8%, and 7% individually). Foreign sales were 59% of revenue. The company also cited competition from larger, better-resourced businesses; dependence on certain limited-source materials; execution and capacity needs as volume grows; foreign-exchange exposure; and risks to intellectual-property protection.
- The June 2012 warrants are treated as a Level 3 liability and remeasured through earnings. FY2016 included a $52,000 warrant fair-value expense, compared with $464,000 expense in FY2015; the liability was $717,000 at year-end. FY2016 also included $305,000 of other expense, primarily related to foreign exchange and China asset/inventory valuation effects.
- The company reported no material legal proceedings, effective management-assessed disclosure controls and internal control over financial reporting, and an unqualified audit opinion on the financial statements. The auditor did not provide an internal-control attestation.
Most important facts for investors to verify
- Whether the ISP acquisition closed, its final cash/note mix, financing sources, approvals, and resulting leverage and dilution.
- Whether FY2017 growth and margin expectations materialized, particularly for HVPMO, infrared, and specialty products; monitor backlog conversion and customer concentration.
- Cash availability and working-capital needs, including the amount of cash held in China and the restrictions and tax consequences on repatriation.
- Production yields, capacity additions, capital spending, and inventory growth relative to sales and demand.
- Potential dilution and earnings volatility from outstanding warrants, stock awards, and other equity-linked instruments.